Literature DB >> 33972418

Wild-type α-synuclein inherits the structure and exacerbated neuropathology of E46K mutant fibril strain by cross-seeding.

Houfang Long1,2, Weitong Zheng1,2, Yang Liu1,2, Yunpeng Sun1,2, Kun Zhao1,2, Zhenying Liu1,2, Wencheng Xia1,2, Shiran Lv1,2, Zhengtao Liu1,2, Dan Li3,4, Kai-Wen He5,2, Cong Liu5,2.   

Abstract

Heterozygous point mutations of α-synuclein (α-syn) have been linked to the early onset and rapid progression of familial Parkinson's diseases (fPD). However, the interplay between hereditary mutant and wild-type (WT) α-syn and its role in the exacerbated pathology of α-syn in fPD progression are poorly understood. Here, we find that WT mice inoculated with the human E46K mutant α-syn fibril (hE46K) strain develop early-onset motor deficit and morphologically different α-syn aggregation compared with those inoculated with the human WT fibril (hWT) strain. By using cryo-electron microscopy, we reveal at the near-atomic level that the hE46K strain induces both human and mouse WT α-syn monomers to form the fibril structure of the hE46K strain. Moreover, the induced hWT strain inherits most of the pathological traits of the hE46K strain as well. Our work suggests that the structural and pathological features of mutant strains could be propagated by the WT α-syn in such a way that the mutant pathology would be amplified in fPD.

Entities:  

Keywords:  E46K mutant; Parkinson’s diseases; cryo-electron microscopy; pathology; α-synuclein

Mesh:

Substances:

Year:  2021        PMID: 33972418      PMCID: PMC8158012          DOI: 10.1073/pnas.2012435118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

1.  The E46K mutation in alpha-synuclein increases amyloid fibril formation.

Authors:  Eric A Greenbaum; Charles L Graves; Amanda J Mishizen-Eberz; Michael A Lupoli; David R Lynch; S Walter Englander; Paul H Axelsen; Benoit I Giasson
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

2.  MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy.

Authors:  Shawn Q Zheng; Eugene Palovcak; Jean-Paul Armache; Kliment A Verba; Yifan Cheng; David A Agard
Journal:  Nat Methods       Date:  2017-02-27       Impact factor: 28.547

3.  Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death.

Authors:  Laura A Volpicelli-Daley; Kelvin C Luk; Tapan P Patel; Selcuk A Tanik; Dawn M Riddle; Anna Stieber; David F Meaney; John Q Trojanowski; Virginia M-Y Lee
Journal:  Neuron       Date:  2011-10-06       Impact factor: 17.173

4.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

5.  Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein.

Authors:  Woong Choi; Shahin Zibaee; Ross Jakes; Louise C Serpell; Bazbek Davletov; R Anthony Crowther; Michel Goedert
Journal:  FEBS Lett       Date:  2004-10-22       Impact factor: 4.124

6.  The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.

Authors:  Juan J Zarranz; Javier Alegre; Juan C Gómez-Esteban; Elena Lezcano; Raquel Ros; Israel Ampuero; Lídice Vidal; Janet Hoenicka; Olga Rodriguez; Begoña Atarés; Verónica Llorens; Estrella Gomez Tortosa; Teodoro del Ser; David G Muñoz; Justo G de Yebenes
Journal:  Ann Neurol       Date:  2004-02       Impact factor: 10.422

7.  E46K-like α-synuclein mutants increase lipid interactions and disrupt membrane selectivity.

Authors:  Matteo Rovere; Alex E Powers; Haiyang Jiang; Julia C Pitino; Luis Fonseca-Ornelas; Dushyant S Patel; Alessandro Achille; Ralf Langen; Jobin Varkey; Tim Bartels
Journal:  J Biol Chem       Date:  2019-05-02       Impact factor: 5.157

8.  Abrogating Native α-Synuclein Tetramers in Mice Causes a L-DOPA-Responsive Motor Syndrome Closely Resembling Parkinson's Disease.

Authors:  Silke Nuber; Molly Rajsombath; Georgia Minakaki; Jürgen Winkler; Christian P Müller; Maria Ericsson; Barbara Caldarone; Ulf Dettmer; Dennis J Selkoe
Journal:  Neuron       Date:  2018-10-10       Impact factor: 17.173

9.  Mutations associated with familial Parkinson's disease alter the initiation and amplification steps of α-synuclein aggregation.

Authors:  Patrick Flagmeier; Georg Meisl; Michele Vendruscolo; Tuomas P J Knowles; Christopher M Dobson; Alexander K Buell; Céline Galvagnion
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-29       Impact factor: 11.205

10.  Cryo-EM structure of alpha-synuclein fibrils.

Authors:  Ricardo Guerrero-Ferreira; Nicholas Mi Taylor; Daniel Mona; Philippe Ringler; Matthias E Lauer; Roland Riek; Markus Britschgi; Henning Stahlberg
Journal:  Elife       Date:  2018-07-03       Impact factor: 8.140

View more
  4 in total

Review 1.  Consequences of variability in α-synuclein fibril structure on strain biology.

Authors:  Sara A M Holec; Samantha L Liu; Amanda L Woerman
Journal:  Acta Neuropathol       Date:  2022-02-04       Impact factor: 17.088

Review 2.  Conformational strains of pathogenic amyloid proteins in neurodegenerative diseases.

Authors:  Dan Li; Cong Liu
Journal:  Nat Rev Neurosci       Date:  2022-05-30       Impact factor: 38.755

3.  Real-Time Fast Amyloid Seeding and Translocation of α-Synuclein with a Nanopipette.

Authors:  Nathan Meyer; Jean-Marc Janot; Joan Torrent; Sébastien Balme
Journal:  ACS Cent Sci       Date:  2022-02-23       Impact factor: 18.728

4.  A NAC domain mutation (E83Q) unlocks the pathogenicity of human alpha-synuclein and recapitulates its pathological diversity.

Authors:  Senthil T Kumar; Anne-Laure Mahul-Mellier; Ramanath Narayana Hegde; Gwladys Rivière; Rani Moons; Alain Ibáñez de Opakua; Pedro Magalhães; Iman Rostami; Sonia Donzelli; Frank Sobott; Markus Zweckstetter; Hilal A Lashuel
Journal:  Sci Adv       Date:  2022-04-29       Impact factor: 14.957

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.